MicroRNA-421 inhibits caspase-10 expression and promotes breast cancer progression

被引:31
|
作者
Hu, T. B. [1 ,2 ]
Chen, H. S. [2 ]
Cao, M. Q. [2 ]
Guo, F. D. [2 ]
Cheng, X. Y. [1 ]
Han, Z. B. [1 ]
Li, M. Q. [1 ]
机构
[1] Dalian Med Univ, Dalian, Peoples R China
[2] Dalian Univ, Affiliated Zhongshan Hosp, Dept Bre & Thyroid Surg, Dalian, Peoples R China
关键词
miRNA-421; caspase-10; apoptosis; breast cancer; DOWN-REGULATION; CARCINOMA; APOPTOSIS; MIR-421; PROLIFERATION; PROGNOSIS; SIGNATURE; ATM;
D O I
10.4149/neo_2018_170306N159
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is one of the most prevalent and fatal diseases around the world. The mechanism of tumorigenesis in breast cancer remains to be clarified. miR-421 plays an oncogenic role in many cancers. Although, the clinical significance of miR-421 in patients with breast cancer is still to he investigated. Caspase-10 is one of the initiator of apoptosis. But the relationship between miR-421 and caspase-10 has not been investigated. In the present study, we found that miR-421 was expressed much higher in breast cancer tissues compared to those in adjacent non-tumor tissues. Furthermore, miR-421 promotes cell proliferation and colony formation in vitro. miR-421 inhibits cell apoptosis probably through restraining caspase-10 expression. Thus, miR-421 might be a potential diagnostic maker and therapeutic target for breast cancer.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [1] MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer
    Zhou, Yifan
    Cheng, Xiaowen
    Wan, Yufeng
    Chen, Tingting
    Zhou, Qing
    Wang, Zhengguang
    Zhu, Huaqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7579 - 7587
  • [2] MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1
    Pan, Yongqin
    Jiao, Genlong
    Wang, Cunchuan
    Yang, Jingge
    Yang, Wah
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 83 : 1398 - 1406
  • [3] Correlation between microRNA-421 expression level and prognosis of gastric cancer
    Liu, Haiyan
    Gao, Yongjian
    Song, Defeng
    Liu, Tong
    Feng, Ye
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 15128 - 15132
  • [4] MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer
    Ge, Xiaoxiao
    Liu, Xinyang
    Lin, Fengjuan
    Li, Peng
    Liu, Kaiyi
    Geng, Ruixuan
    Dai, Congqi
    Lin, Ying
    Tang, Wenbo
    Wu, Zheng
    Chang, Jinjia
    Lu, Jianwei
    Li, Jin
    ONCOTARGET, 2016, 7 (17) : 24466 - 24482
  • [5] MiCroRNA-421 promotes the proliferation and metastasis of gastric cancer cells by targeting claudin-11
    Yang, Peng
    Zhang, Mei
    Liu, Xiting
    Pu, Huayun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 2625 - 2632
  • [6] MicroRNA-421 promotes the progression of non-small cell lung cancer by targeting HOPX and regulating the Wnt/β-catenin signaling pathway
    Liang, Huagang
    Wang, Chao
    Gao, Kun
    Li, Jian
    Jia, Rui
    MOLECULAR MEDICINE REPORTS, 2019, 20 (01) : 151 - 161
  • [7] Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer
    Xu, Bing
    Zhou, Zong-Guang
    Li, Yuan
    Wang, Ling
    Yang, Lie
    Zhou, Bin
    Liu, Hai-Yi
    Song, Jun-Min
    Zeng, Yu-Jian
    Wang, Rong
    Shen, Xiao-Gang
    Sun, Xiao-Feng
    ONCOLOGY, 2008, 74 (3-4) : 229 - 236
  • [8] Metformin-induced activation of caspase-10 inhibits lung adenocarcinoma progression and metastasis
    Kumari, R.
    Das, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Gastric juice microRNA-421 is a new biomarker for screening gastric cancer
    Zhang, Xinjun
    Cui, Long
    Ye, Guoliang
    Zheng, Tuo
    Song, Haojun
    Xia, Tian
    Yu, Xiuchong
    Xiao, Bingxiu
    Le, Yanping
    Guo, Junming
    TUMOR BIOLOGY, 2012, 33 (06) : 2349 - 2355
  • [10] MicroRNA-421 mediates immunosensitivity in late-stage human liver cancer
    Zhou, Rui
    Yang, Bin
    Wu, Xinmou
    Su, Min
    Li, Rong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8510 - 8514